Sorted By:

Relevance


Researching Cancer Medicines: Setbacks and Stepping Stones

PhRMA  |  Report

A cancer diagnosis can be devastating to individuals faced with the disease, along with their families and caregivers supporting them in their fight. While recent scientific advances have led to improved prevention, earlier diagnoses, and innovative treatments for many cancers, there is still tre...
https://www.phrma.org/report/researching-cancer-medicines-setbacks-and-stepping-stones

Ask About Adherence: Q&A on appointment-based medication synchronization

PhRMA  |  Blog Post

Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources.
http://catalyst.phrma.org/ask-about-adherence-qa-on-appointment-based-medication-synchronization

A Decade of Innovation in Cancer

PhRMA  |  Report

Cancer, in its many forms, has long been one of the most devastating and confounding health concerns worldwide. Characterized by the uncontrolled growth and spread of abnormal cells, cancers wreak havoc on the body and, if left unchecked, can lead to malfunction of various health systems ...
https://www.phrma.org/report/a-decade-of-innovation-in-cancer

The Global Economic Cost of Cancer

PhRMA  |  Report

Cancer is taking an enormous human toll around the world and is a growing threat in low- to middle-income countries. And little has been known about what that toll means in dollars, until now....
https://www.phrma.org/report/the-global-economic-cost-of-cancer

Manager - Public Affairs

PhRMA  |  PhRMA Career

Create agendas, presentation materials and summary/compilation reports.
https://www.phrma.org/careers/manager-public-affairs

The Next Five Years of PDUFA VI: Driving the availability of innovative treatments for patients

PhRMA  |  Blog Post

PDUFA VI helps provide much-needed resources to the agency to meaningfully advance these efforts.
http://catalyst.phrma.org/the-next-five-years-of-pdufa-vi-driving-the-availability-of-innovative-treatments-for-patients

Medicamentos en Desarrollo para la Diabetes

PhRMA  |  Report

La epidemia de diabetes en los Estados Unidos afecta a millones de estadounidenses, con 1,4 millones de casos nuevos diagnosticados cada año. Para muchos pacientes, un diagnóstico de diabetes afecta casi todos los aspectos de, su vida, incluidas las preocupaciones de una dieta especial y otros ca...
https://www.phrma.org/report/medicamentos-en-desarrollo-para-la-diabetes

An Analysis of Exchange Plan Benefits for Certain Medicines

PhRMA  |  Report

A new report demonstrates that the majority of plans in the Health Insurance Exchanges are placing a significant out-of-pocket burden on patients with serious illnesses by requiring particularly high cost-sharing for all medicines used to treat certain conditions. 
https://www.phrma.org/report/an-analysis-of-exchange-plan-benefits-for-certain-medicines

Medicare Monday: Same bad ideas continue to threaten Part D and beneficiary access to medicines

PhRMA  |  Blog Post

Furthermore, the CBO reports that Medicaid-style rebates in Part D could stifle innovation for breakthrough treatments for conditions like Parkinson’s, arthritis and osteoporosis that disproportionately impact the elderly.
http://catalyst.phrma.org/medicare-monday-same-bad-ideas-continue-to-threaten-part-d-and-beneficiary-access-to-medicines

Ask About Adherence: New study examines effects of synchronized prescription refill program on medication adherence

PhRMA  |  Blog Post

“[P]rescription synchronization alone did not appear to lead to the same magnitude of improvement that has been reported in studies of appointment-based medication synchronization programs, which typically offer face-to-face contact with a pharmacist and a more comprehensive set of services….”
http://catalyst.phrma.org/ask-about-adherence-new-study-examines-effects-of-synchronized-prescription-refill-program-on-medication-adherence

List of 2015 Medicines in Development for Heart Disease and Stroke

PhRMA  |  Report

The List of 2015 Medicines in Development for Heart Disease and Stroke Report outlines the medicines in development, including its product name, sponsor, indication and development status, for the following cardiovascular diseases: Acute Coronary Syndrome, Adjunctive Therapies, Arrhythmia/Atrial Fibrillation, Atherosclerosis, Cardiomyopathy, Coronary Artery Disease, Heart Attack, Heart Failure, Hypertension, Lipid Disorders, Peripheral Vascular Disease, Pulmonary Vascular Disease, Stroke, and Thrombosis.
https://www.phrma.org/report/list-of-2015-medicines-in-development-for-heart-disease-and-stroke

Drug Importation

PhRMA  |  From PhRMA

However, these schemes fail to acknowledge that the resources required to ensure the safety and efficacy of any drugs being imported from or passing through other countries into the United States would outweigh any potential savings.
https://www.phrma.org/advocacy/safety/drug-importation

List of 2016 Medicines in Development for Alzheimer's

PhRMA  |  Report

This report outlines the medicines in development for Alzheimer's Disease including the drug name, sponsor, indication and development phase.
https://www.phrma.org/report/list-of-2016-medicines-in-development-for-alzheimer-s

Recognizing the Value of Innovation in Rheumatoid Arthritis

PhRMA  |  Report

Significant progress has been made in recent years in our ability to diagnose and treat rheumatoid arthritis (RA), a devastating autoimmune disease that causes progressive joint deterioration and pain in millions of Americans. Therapeutic advances have transformed the RA treatment paradigm over t...
https://www.phrma.org/report/recognizing-the-value-of-innovation-in-rheumatoid-arthritis

List of 2016 Medicines in Development for Rare Diseases

PhRMA  |  Report

This report outlines the list of Medicines in Development for rare diseases and includes the product name, sponsor, official FDA designation and development status.
https://www.phrma.org/report/list-of-2016-medicines-in-development-for-rare-diseases

2015 PhRMA Profile: Annual Membership Survey Results

PhRMA  |  Report

R&D Expenditures: Expenditures within PhRMA member companies’ US and/or foreign research laboratories plus research and development (R&D) funds contracted or granted to commercial laboratories, private practitioners, consultants, educational and nonprofit research institutions, manufacturing a...
https://www.phrma.org/report/2015-phrma-profile-annual-membership-survey-results

Biopharmaceutical Industry Speakers List

PhRMA  |  Report

The Biopharmaceutical Industry Speakers List contains names of executives at the Pharmaceutical Research and Manufacturers of America (PhRMA) and its member companies available to participate in events and panel discussions on the cost and value of prescription medicines. A photo, biography and c...
https://www.phrma.org/report/biopharmaceutical-industry-speakers-list

How the Bayh-Dole Act Propelled U.S. Global Leadership in Life Sciences

PhRMA  |  Report

The University and Small Business Patent Procedures Act of 1980 (commonly referred to as “Bayh-Dole”) created the uniform framework that facilitates orderly and efficient technology transfer from universities and other institutions receiving government research funding to the private sector. Bayh...
https://www.phrma.org/report/how-the-bayh-dole-act-propelled-u-s-global-leadership-in-life-sciences

Medicare Monday: Catch up on MedPAC and its Part B recommendations

PhRMA  |  Blog Post

For policy wonks, you can get up to speed with our Memorial Day reading list on the Medicare Payment Advisory Commission (MedPAC), how it informs Medicare policy and its recent Part B recommendations, which are expected to be included in their report to Congress this June.
http://catalyst.phrma.org/medicare-monday-catch-up-on-medpac-and-its-part-b-recommendations

Glossary of Terms - Rare Diseases

PhRMA  |  Report

acquired immune deficiency syndrome (AIDS)—A manifestation of infection with the human inimunodeficiency virus (HIV) characterized by the presence of one or more opportunistic diseases which occur primarily, or in some cases only, when an individual’s immune system function is de...
https://www.phrma.org/report/glossary-of-terms-rare-diseases

Medicines in Development for Women Backgrounder

PhRMA  |  Report

Breast cancer Breast cancer affected an estimated 207,090 American women and killed 39,840 in 2010, according to the American Cancer Society. One medicine now in clinical trials for metastatic breast cancer combines two treatment approaches into one medicine – a targeted monoclonal anti...
https://www.phrma.org/report/medicines-in-development-for-women-backgrounder

Policy Solutions: Addressing Market Distortions

PhRMA  |  Report

A well-functioning market can ensure patient access to innovative medicines without sacrificing investment in future treatments and cures. The market-based U.S. health care system has worked well over time, but more can be done to help it work even better. Addressing distortions would help improv...
https://www.phrma.org/report/policy-solutions-addressing-market-distortions

Significant progress fighting cancer: Death rate has dropped 25 percent

PhRMA  |  Blog Post

Researchers continue to better understand the disease’s complexities, and today, there are more than 800 medicines and vaccines in clinical testing for cancer – approximately 80 percent of which are potentially the first of their kind.
http://catalyst.phrma.org/significant-progress-fighting-cancer-death-rate-has-dropped-25

Researching Alzheimer’s Medicines: Setbacks and Stepping Stones

PhRMA  |  Report

Alzheimer’s disease is a devastating disease that causes individuals to lose their memories, independence, relationships, and, ultimately, their lives. Family and caregivers face many challenges as they care for a loved one who is gradually slipping away. From a societal perspective, Alzheimer’s ...
https://www.phrma.org/report/researching-alzheimer-s-medicines-setbacks-and-stepping-stones

Zika Virus: Current Outbreak and Ongoing Research Efforts

PhRMA  |  Report

The Zika virus is a tropical, mosquito-borne illness that is transmitted after being bitten by the Aedes mosquito – the same type of mosquito that spreads Dengue, Chikungunya, and Yellow Fever. Symptoms of the disease are usually mild, including fever, joint pain, rashes, and viral conjunct...
https://www.phrma.org/report/zika-virus-current-outbreak-and-ongoing-research-efforts

You have reviewed the first 250 results out of 1012. Each page contains 25 results. You're on page 10.

prev 7 8 9 10 11 12 next